A Record Number of FDA Drug Approvals in 2018 Is Followed by an Encouraging Start for 2019

Following a record number of approvals in 2018, the FDA has recently approved two new drugs with many more anticipated approvals later in the year. Trazimera to Treat Human Epidermal…

Continue Reading A Record Number of FDA Drug Approvals in 2018 Is Followed by an Encouraging Start for 2019
Cancer Rates Overall Have Been Dropping But It’s Not All Good News, Report Shows
Source: Pixabay

Cancer Rates Overall Have Been Dropping But It’s Not All Good News, Report Shows

The State of Cancer in the United States A recent report posted by the American Cancer Society has indicated that cancer rates in the United States have been continuously falling over…

Continue Reading Cancer Rates Overall Have Been Dropping But It’s Not All Good News, Report Shows

New Research Approach to Improve Outcomes for Those with Metastatic Breast Cancer and More

  According to UWHealth, the researchers at UW Carbone Cancer Center look behind the five-year survival rate for cancer and instead consult what they call their "core facility--Cancer Prevention and…

Continue Reading New Research Approach to Improve Outcomes for Those with Metastatic Breast Cancer and More
New Drug Extending Life for Those with Metastatic Breast Cancer Approved in England
Source: Pixabay

New Drug Extending Life for Those with Metastatic Breast Cancer Approved in England

The Westmorland Gazette reports that a new drug called Perjeta, has been given the thumbs up to treat women with metastatic breast cancer in England. Metastatic breast cancer is when one's…

Continue Reading New Drug Extending Life for Those with Metastatic Breast Cancer Approved in England
A Treatment For Metastatic Breast Cancer Shows Promise In Early Trials
source: pixabay.com

A Treatment For Metastatic Breast Cancer Shows Promise In Early Trials

According to a story from Financial Buzz, the pharmaceutical company BriaCell announced some preliminary results for the ongoing clinical trials of its experimental treatment Bria-IMT. This treatment is an immunotherapy…

Continue Reading A Treatment For Metastatic Breast Cancer Shows Promise In Early Trials
A New Breast Cancer Treatment Study Just Entered Phase 3
SavanasDesign / Pixabay

A New Breast Cancer Treatment Study Just Entered Phase 3

According to an article from businesswire.com, the pharmaceutical company Odonate Therapeutics announced the beginning of CONTESSA, a phase three study of the treatment tesetaxel and its function in patients with…

Continue Reading A New Breast Cancer Treatment Study Just Entered Phase 3
Close Menu